Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

  • Bisphosphonates: alendronate, risedronate, zoledronic acid, pamidronate
  • Selective oestrogen modulating drugs: raloxifene
  • RANK Lipid Inhibitors: denosumab, stronitium ranelate
  • Anabolic drigs: teriparatide or pamathyroid tumor hormone (1-34)



Warning

If a patient has new results such as pathology or medications that indicate the condition exists after a patient has been reviewed, the patient will appear again on the 'indicated condition' report. For example:

  1. A patient taking anti-diabetic medication since many years but the patient doesn't have diabetes and has thus been removed from the 'indicated diabetes without diagnosis' report and the respective Topbar prompt
  2. This patient has a FBG and/or HbA1c done and the values indicate that the patient might have diabetes, but no diagnosis is recorded.
  3. Now the patient appears again on the 'indicated diabetes without diagnosis' report and will receive the prompt in Topbar